Treatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCell CycleAntineoplastic AgentsCombined Modality TherapyCisplatinDoxorubicinCyclophosphamideNeoadjuvant TherapyDisease-Free SurvivalBreast NeoplasmsEtoposideMenstrual CycleNeoplasm StagingSurvival AnalysisDrug Administration SchedulePrognosisLung NeoplasmsSurvival RateMethotrexatePaclitaxelCarboplatinVinblastineInduction ChemotherapyTaxoidsCell Cycle ProteinsNeoplasm Recurrence, LocalIfosfamideDrug Resistance, NeoplasmNeoplasmsDeoxycytidineBleomycinAntimetabolites, AntineoplasticTime FactorsOrganoplatinum CompoundsAntineoplastic Agents, AlkylatingAnthracyclinesCytarabineCarcinoma, Non-Small-Cell LungFollow-Up StudiesChemotherapy, Cancer, Regional PerfusionOvarian NeoplasmsNeoplasm MetastasisSalvage TherapyAntineoplastic Agents, PhytogenicNeutropeniaAdenocarcinomaEstrous CycleVomitingTesticular NeoplasmsNauseaTransplantation, AutologousLymphoma, Non-HodgkinHodgkin DiseaseRadiotherapy, AdjuvantCell Line, TumorColorectal NeoplasmsAntibiotics, AntineoplasticProspective StudiesRadiotherapyDose-Response Relationship, DrugCamptothecinGranulocyte Colony-Stimulating FactorCitric Acid CycleCarmustineNeoplasms, Germ Cell and EmbryonalClinical Trials as TopicDacarbazineKaplan-Meier EstimateLomustineBrain NeoplasmsBone NeoplasmsInfusions, IntravenousOsteosarcomaPlatinum CompoundsLeukopeniaMitomycinLiver NeoplasmsMelphalanInfusions, Intra-ArterialApoptosisAntiemeticsTumor Markers, BiologicalThiotepaMitoxantroneHematopoietic Stem Cell TransplantationStomach NeoplasmsPeritoneal NeoplasmsRecurrenceLymphatic MetastasisDrug TherapyAntibodies, Monoclonal, HumanizedCell Cycle CheckpointsTegafurGerminomaPalliative CareCarcinoma, Squamous CellCarcinomaDaunorubicin